Nom du produit:2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

IUPAC Name:2,6-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

CAS:890839-23-3
Formule moléculaire:C15H21BO4
Pureté:97%
Numéro de catalogue:CM218186
Poids moléculaire:276.14

Unité d'emballage Stock disponible Prix($) Quantité
CM218186-5g in stock ƛƥȺȐ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:890839-23-3
Formule moléculaire:C15H21BO4
Point de fusion:-
Code SMILES:O=C(O)C1=C(C)C=C(B2OC(C)(C)C(C)(C)O2)C=C1C
Densité:
Numéro de catalogue:CM218186
Poids moléculaire:276.14
Point d'ébullition:
N° Mdl:MFCD23379533
Stockage:

Category Infos

Boronic Acids and Esters
Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).
Boronic Acid For Sale
Find trusted boronic acid for sale. Any requirements and problems can ask us at any time.
New
Custom Organic Synthesis,Where to Buy Chemical Building Blocks - Chemenu
Pharmaceutical intermediates, bulk products, chiral, achiral, heterocycles, metal catalysts, amino acids, peptides, benzene, pyridine, pyrazine, triazine, piperidine, piperazine, morpholine, imidazoline, cyclopropane, indole, benzotriazole, anthranil, quinoline, naphthalene, boronic compounds, fluorination, oxidation, rearrangement reaction
Chemenu product lines cover amino acids and peptides, heterocyclic compounds, alkanes and aromatic compounds, carbohydrates, alcohols, aldehydes & ketones, pyridazines, metal catalysts and other pharmaceutical intermediates. For more custom organic synthesis, please contact us for a quote.

Related Products



Product Other Information

Product Overview 2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (2,6-DM-4-TMBDA) is an organic compound that is commonly used in scientific research. It is a derivative of benzoic acid and is part of a larger family of compounds known as dioxaborolanes. 2,6-DM-4-TMBDA has been used in a variety of applications, including synthesis, biochemical research, and drug development.
Synthesis and Application 2,6-DM-4-TMBDA is synthesized through the boron-mediated condensation of benzoic acid and 4-tetramethyl-1,3,2-dioxaborolane. This reaction is conducted in the presence of a catalytic amount of a Lewis acid, such as zinc chloride. The reaction is carried out in aprotic solvents, such as dichloromethane or toluene, at temperatures ranging from 0 to 20°C. The reaction yields a mixture of 2,6-DM-4-TMBDA and 2,6-di-tert-butyl-4-tetramethyl-1,3,2-dioxaborolane. 2,6-DM-4-TMBDA has been used in a variety of scientific research applications. It has been used as a catalyst in the synthesis of a variety of organic compounds, such as esters, amides, and nitriles. It has also been used as a ligand for transition metal complexes, which can be used in catalysis and other applications. 2,6-DM-4-TMBDA has also been used as a reagent in the synthesis of peptides and peptidomimetics, as well as in the synthesis of biologically active compounds, such as inhibitors of protein-protein interactions.
Future Directions The future directions of 2,6-DM-4-TMBDA research are numerous. One potential direction is the use of 2,6-DM-4-TMBDA as a catalyst in the synthesis of pharmaceuticals, such as antibiotics and anti-cancer drugs. Another potential direction is the use of 2,6-DM-4-TMBDA as a reagent in the synthesis of peptides and peptidomimetics, which could be used to develop new drugs. Additionally, 2,6-DM-4-TMBDA could be used in the synthesis of biologically active compounds, such as inhibitors of protein-protein interactions. Finally, 2,6-DM-4-TMBDA could be used in the synthesis of biodegradable polymers, which could be used for a variety of applications, including drug delivery.